Cipher Pharmaceuticals, Inc. (CPH.TO)
14.17
+0.56
(+4.11%)
CAD |
TSX |
Nov 13, 16:00
Cipher Pharmaceuticals Price to Book Value : 1.721 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.721 |
| November 12, 2026 | 1.653 |
| November 11, 2026 | 1.666 |
| November 10, 2026 | 1.656 |
| November 09, 2026 | 1.670 |
| November 06, 2026 | 1.641 |
| November 05, 2026 | 1.618 |
| November 04, 2026 | 1.583 |
| November 03, 2026 | 1.588 |
| November 02, 2026 | 1.603 |
| October 30, 2026 | 1.585 |
| October 29, 2026 | 1.640 |
| October 28, 2026 | 1.640 |
| October 27, 2026 | 1.592 |
| October 26, 2026 | 1.617 |
| October 23, 2026 | 1.626 |
| October 22, 2026 | 1.658 |
| October 21, 2026 | 1.617 |
| October 20, 2026 | 1.609 |
| October 19, 2026 | 1.609 |
| October 16, 2026 | 1.609 |
| October 15, 2026 | 1.643 |
| October 14, 2026 | 1.622 |
| October 13, 2026 | 1.640 |
| October 09, 2026 | 1.658 |
| Date | Value |
|---|---|
| October 08, 2026 | 1.658 |
| October 07, 2026 | 1.659 |
| October 06, 2026 | 1.684 |
| October 05, 2026 | 1.664 |
| October 02, 2026 | 1.658 |
| October 01, 2026 | 1.658 |
| September 30, 2026 | 1.658 |
| September 29, 2026 | 1.787 |
| September 28, 2026 | 1.782 |
| September 25, 2026 | 1.813 |
| September 24, 2026 | 1.835 |
| September 23, 2026 | 1.862 |
| September 22, 2026 | 1.896 |
| September 21, 2026 | 1.882 |
| September 18, 2026 | 1.915 |
| September 17, 2026 | 1.939 |
| September 16, 2026 | 1.894 |
| September 15, 2026 | 1.900 |
| September 14, 2026 | 1.928 |
| September 11, 2026 | 1.866 |
| September 10, 2026 | 1.853 |
| September 09, 2026 | 1.858 |
| September 08, 2026 | 1.847 |
| September 04, 2026 | 1.872 |
| September 03, 2026 | 1.878 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| HLS Therapeutics, Inc. | 1.551 |
| Bausch Health Cos., Inc. | -- |
| BioSyent, Inc. | 4.401 |
| Revive Therapeutics Ltd. | -- |
| Knight Therapeutics, Inc. | 1.490 |
Price to Book Value Related Metrics
| PE Ratio | 7.700 |
| PS Ratio | 5.356 |
| PEG Ratio | 0.0791 |
| Price to Free Cash Flow | 11.12 |
| Price | 14.17 |
| Earnings Yield | 12.99% |
| Market Cap | 360.13M |
| PEGY Ratio | 0.0791 |
| Operating PE Ratio | 13.61 |
| Normalized PE Ratio | 8.057 |